Antibody response to the pneumococcal proteins pneumococcal surface adhesin A and pneumolysin in children with acute otitis media. 2001

S Rapola, and T Kilpi, and M Lahdenkari, and P H Mäkelä, and H Käyhty
National Public Health Institute, Helsinki, Finland.

BACKGROUND Pneumococcal surface adhesin A (PsaA) and pneumolysin (Ply) are common to virtually all Streptococcus pneumoniae isolates, and they are immunogenic and protective against pneumococcal challenge in experimental animals. We have recently shown production of antibodies to PsaA and Ply in young children, but data on the immune response to these antigens during culture-confirmed pneumococcal infection are lacking. OBJECTIVE To evaluate whether young children respond to S. pneumoniae by producing antibodies to PsaA and Ply during acute otitis media (AOM). METHODS A cohort of 329 children was followed prospectively from the age of 2 months to the age of 2 years. Paired sera were obtained during episodes of AOM and used to measure antibodies to PsaA and Ply by enzyme-linked immunosorbent assay. S. pneumoniae cultured from the middle ear fluid was taken as evidence of pneumococcal AOM. The presence of S. pneumoniae in the nasopharyngeal aspirate collected in connection of AOM or any other respiratory infection or in the nasopharyngeal swab collected at scheduled visits was taken to indicate pneumococcal carriage and thus a history of previous contact with S. pneumoniae. RESULTS Children with previous pneumococcal contacts had high anti-PsaA and anti-Ply concentrations in the acute phase sera regardless of the nature (AOM or carriage) of the current pneumococcal contact. Of the children with no previous pneumococcal contact, those with current pneumococcal AOM had lower antibody concentrations than those with current pneumococcal carriage only. Anti-PsaA and anti-Ply responses were found in children with current pneumococcal contact. The antibody response was strongly associated with low acute phase antibody concentration, but not significantly with age and the nature of the current pneumococcal contact. CONCLUSIONS We showed that infants are capable of developing a specific antibody response to the pneumococcal proteins PsaA and Ply during AOM.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D010033 Otitis Media Inflammation of the MIDDLE EAR including the AUDITORY OSSICLES and the EUSTACHIAN TUBE. Middle Ear Inflammation,Inflammation, Middle Ear
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005387 Finland A country in northern Europe, bordering the Baltic Sea, Gulf of Bothnia, and Gulf of Finland, between Sweden and Russia. The capital is Helsinki. Aland Islands,Åland Islands
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody

Related Publications

S Rapola, and T Kilpi, and M Lahdenkari, and P H Mäkelä, and H Käyhty
March 2001, The Journal of infectious diseases,
S Rapola, and T Kilpi, and M Lahdenkari, and P H Mäkelä, and H Käyhty
November 1995, Clinical and diagnostic laboratory immunology,
S Rapola, and T Kilpi, and M Lahdenkari, and P H Mäkelä, and H Käyhty
January 2000, Acta oto-laryngologica. Supplementum,
S Rapola, and T Kilpi, and M Lahdenkari, and P H Mäkelä, and H Käyhty
March 2002, The Pediatric infectious disease journal,
S Rapola, and T Kilpi, and M Lahdenkari, and P H Mäkelä, and H Käyhty
November 1995, Acta oto-laryngologica,
S Rapola, and T Kilpi, and M Lahdenkari, and P H Mäkelä, and H Käyhty
January 1982, Pediatric infectious disease,
S Rapola, and T Kilpi, and M Lahdenkari, and P H Mäkelä, and H Käyhty
February 1996, The Pediatric infectious disease journal,
S Rapola, and T Kilpi, and M Lahdenkari, and P H Mäkelä, and H Käyhty
July 2009, Vaccine,
S Rapola, and T Kilpi, and M Lahdenkari, and P H Mäkelä, and H Käyhty
June 1974, Infection and immunity,
S Rapola, and T Kilpi, and M Lahdenkari, and P H Mäkelä, and H Käyhty
February 2000, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
Copied contents to your clipboard!